(Q51016419)

English

Effects of age and sex on the pharmacokinetics of LCZ696, an angiotensin receptor neprilysin inhibitor.

scientific article published on 12 June 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/26073563

Effects of age and sex on the pharmacokinetics of LCZ696, an angiotensin receptor neprilysin inhibitor. (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/26073563

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Lu Gan

1

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/26073563

Thomas Langenickel

2

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/26073563

Jesika Petruck

3

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/26073563

Kiran Kode

4

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/26073563

Iris Rajman

5

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/26073563

Priya Chandra

6

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/26073563

Wei Zhou

7

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/26073563

Sam Rebello

8

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/26073563

Gangadhar Sunkara

9

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/26073563

publication date

12 June 2015

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/26073563

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/26073563

56

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/26073563

1

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/26073563

78-86

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/26073563

Pharmacokinetics and pharmacodynamics of LCZ696, a novel dual-acting angiotensin receptor-neprilysin inhibitor (ARNi).

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.571

21 January 2018

Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.571

21 January 2018

Dual neurohormonal intervention in CV disease: angiotensin receptor and Neprilysin inhibition

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.571

21 January 2018

Novel roles of nuclear angiotensin receptors and signaling mechanisms

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.571

21 January 2018

AT2 receptor agonists: hypertension and beyond

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.571

21 January 2018

The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.571

21 January 2018

Angiotensin-neprilysin inhibition versus enalapril in heart failure

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.571

21 January 2018

Principles of drug therapy for the elderly patient

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.571

21 January 2018

Gender differences in drug responses

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.571

21 January 2018

Sex differences in pharmacokinetics and pharmacodynamics

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.571

21 January 2018

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.571

21 January 2018

Age-dependent changes of the kidneys: pharmacological implications

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.571

21 January 2018

The aging liver: structural and functional changes and their consequences for drug treatment in old age.

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.571

21 January 2018

Baseline characteristics and treatment of patients in prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF).

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.571

21 January 2018

Evaluation of the relationship between sex, polymorphisms in CYP2C8 and CYP2C9, and pharmacokinetics of angiotensin receptor blockers

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.571

21 January 2018

Identifiers

10.1002/JCPH.571

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/26073563

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/26073563

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51016419&oldid=2143798301"